This year’s conference will emphasize advanced techniques, evidence-based medicine, and live case transmissions featuring the world’s leading experts in CTO stenting. Sessions showcasing the latest research on CTOs will focus on procedural outcomes, registry updates, and new stent technologies. Among the highlights are:
Long-term Data from 2nd Generation DESJochen Wöhrle, MDUniversity Hospital Ulm
Clinical Outcome from Contemporary CTO-PCIDavid E. Kandzari, MDPiedmont Heart Institute
A Japanese Registry UpdateYasushi Asakura, MDKasai Shoikai Hospital
European Registry UpdateGeorgios Sianos, MDAHEPA University Hospital
Progress CTO Registry UpdateEmmanouil S. Brilakis, MDVA North Texas Health Care System and UT Southwestern Medical Center
A Glimpse into the Future: BVS for CTOAntonio Serra, MDHospital de Sant Pau
WHY:A complete blockage in the coronary artery lasting more than three months, or chronic total occlusion (CTO), has historically been one of the most challenging types of blockages to treat with an interventional procedure. Leading practitioners of percutaneous coronary intervention (PCI) must become experts at restoring blood flow for patients with chronic total occlusions, and with advanced techniques, success rates greater than 90% may be obtained. This meeting is aimed at helping interventional cardiologists to optimize success in chronic total coronary occlusions.
WHEN: February 26-27, 2015
WHERE:New York Hilton Midtown1355 Avenue of the AmericasNew York, NY
WHO:The course directors for the CTO Summit 2015 are: J. Aaron Grantham, MDUniversity of Missouri Kansas City and Mid America Heart Institute
Dimitri Karmpaliotis, MD, PhDColumbia University Medical Center
Martin B. Leon, MDNewYork-Presbyterian Hospital/Columbia University Medical Center
Jeffrey W. Moses, MDNewYork-Presbyterian Hospital/Columbia University Medical Center
Masahiko Ochiai, MDShowa University Northern Yokohama Hospital
Gregg W. Stone, MDColumbia University Medical Center / New York-Presbyterian Hospital
Gerald S. Werner, MDKlinikum Darmstadt
HOW TO REGISTER:Media may apply for registration by emailing [email protected]. For those unable to attend in person, reporters are eligible for access to Virtual CTO which provides live and on-demand viewing of the meeting sessions.
About CRFThe Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with heart disease through high quality research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. For more information, visit www.crf.org.
###